Phadia develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases.
The corporate headquarters are located in Uppsala, Sweden.
u Phadia is the world-leader in allergy IgE testing.
u Phadia has 75% market share in in vitro allergy testing worldwide.
u Phadia has 42% in autoimmune disease testing in Europe.